Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Thursday, November 28, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities. This investment is a direct response to the rapid rate of adoption of the Company’s Translational Pharmaceutics ...
read more
Monday, February 06, 2017
Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early ...
read more
Quivive Pharma has entered into service agreements with Camargo Pharmaceutical Services.
read more
QuintilesIMS announced the general availability of a new category of pharmaceuticals commercial operations SaaS software called Orchestrated Customer Engagement (OCE) in the winter of 2017.
read more
Thursday, October 27, 2016
Life sciences companies increasingly are seeking new models to connect expanding sets of disparate, non-identified patient-level data streams to better develop and commercialize next-generation medicines. The need for practical, evidence-based ...
read more
Tuesday, November 22, 2016
QuintilesIMS will lead a collaborative initiative involving founding partners Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, Darmstadt, Germany and Pfizer, which aims to provide clearer and more proactive insight into how anti-cancer ...
read more
Quintiles, the world’s leading global biopharmaceutical services company, today announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012. Presented at the World Vaccine Congress ...
read more
For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress now under way in Washington, D.C., the awards recognize and ...
read more
To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging...
read more
Thursday, February 11, 2016
Quintiles Transnational Holdings Inc. has reported its financial results for the quarter and year ended December 31, 2015.
read more
Tuesday, October 20, 2015
Quintiles announced that Kevin Gordon, currently serving as Executive Vice President, Operations and Chief Financial Officer (CFO), has been promoted to Chief Operating Officer (COO) and that Michael McDonnell is expected to join Quintiles in ...
read more
Friday, December 11, 2015
Quintiles, a provider of biopharmaceutical services, has announced the launch of its Integrated Asset Development Plan (IADP) offering.
read more
Quintiles a provider of product development and integrated healthcare services, has announced its Precision Enrollment offering.
read more
Quintiles has announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency ...
read more